Literature DB >> 26916344

Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis.

Francesca Faustini1,2, David Simon1, Isabelle Oliveira1, Arnd Kleyer1, Judith Haschka1,3, Matthias Englbrecht1, Alan Rodrigues Cavalcante4, Sebastian Kraus1, Taiane Ponte Tabosa4, Camille Figueiredo1, Axel J Hueber1, Roland Kocijan1,3, Alexander Cavallaro5, Georg Schett1, Michael Sticherling6, Jürgen Rech1.   

Abstract

OBJECTIVES: To search for subclinical inflammatory joint disease in patients with psoriasis without psoriatic arthritis (PsA), and to determine whether such changes are associated with the later development of PsA.
METHODS: Eighty-five subjects without arthritis (55 with psoriasis and 30 healthy controls) received high field MRI of the hand. MRI scans were scored for synovitis, osteitis, tenosynovitis and periarticular inflammation according to the PsAMRIS method. Patients with psoriasis additionally received complete clinical investigation, high-resolution peripheral quantitative CT for detecting erosions and enthesiophytes and were followed up for at least 1 year for the development of PsA.
RESULTS: 47% of patients with psoriasis showed at least one inflammatory lesion on MRI. Synovitis was the most prevalent inflammatory lesion (38%), while osteitis (11%), tenosynovitis (4%) and periarticular inflammation (4%) were less frequent. The mean (±SD) PsAMRIS synovitis score was 3.0±2.5 units. Enthesiophytes and bone erosions were not different between patients with psoriasis with or without inflammatory MRI changes. The risk for developing PsA was as high as 60% if patients had subclinical synovitis and symptoms related to arthralgia, but only 13% if patients had normal MRIs and did not report arthralgia.
CONCLUSIONS: Prevalence of subclinical inflammatory lesions is high in patients with cutaneous psoriasis. Arthralgia in conjunction with MRI synovitis constitutes a high-risk constellation for the development of PsA. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Magnetic Resonance Imaging; Psoriatic Arthritis; Synovitis

Mesh:

Year:  2016        PMID: 26916344     DOI: 10.1136/annrheumdis-2015-208821

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

1.  Bone microstructure and volumetric bone mineral density in patients with hyperuricemia with and without psoriasis.

Authors:  D Simon; J Haschka; C Muschitz; A Kocijan; A Baierl; A Kleyer; G Schett; S Kapiotis; H Resch; M Sticherling; J Rech; R Kocijan
Journal:  Osteoporos Int       Date:  2020-01-10       Impact factor: 4.507

2.  The preclinical phase of PsA: a challenge for the epidemiologist.

Authors:  Alexis Ogdie
Journal:  Ann Rheum Dis       Date:  2017-03-08       Impact factor: 19.103

3.  Magnetic resonance imaging (MRI) of feet demonstrates subclinical inflammatory joint disease in cutaneous psoriasis patients without clinical arthritis.

Authors:  Ashish J Mathew; Paul Bird; Ankan Gupta; Renu George; Debashish Danda
Journal:  Clin Rheumatol       Date:  2017-12-04       Impact factor: 2.980

4.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2017 MauiDerm Meeting.

Authors:  Jo Ann LeQuang
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

5.  Comparison of bone structure and microstructure in the metacarpal heads between patients with psoriatic arthritis and healthy controls: an HR-pQCT study.

Authors:  D Wu; J F Griffith; S H M Lam; P Wong; J Yue; L Shi; E K Li; I T Cheng; T K Li; V W Hung; L Qin; L-S Tam
Journal:  Osteoporos Int       Date:  2020-01-14       Impact factor: 4.507

Review 6.  Strategies to Improve Outcomes in Psoriatic Arthritis.

Authors:  Christopher Ritchlin; Jose U Scher
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

7.  Clinicians' perspectives of shared care of psoriatic arthritis and psoriasis between rheumatology and dermatology: an interview study.

Authors:  Daniel Sumpton; Elyssa Hannan; Ayano Kelly; David Tunnicliffe; Andrew Ming; Geraldine Hassett; Jonathan C Craig; Allison Tong
Journal:  Clin Rheumatol       Date:  2020-09-15       Impact factor: 2.980

8.  Dual energy CT iodine map for delineating inflammation of inflammatory arthritis.

Authors:  Takeshi Fukuda; Yoshinori Umezawa; Akihiko Asahina; Hidemi Nakagawa; Kazuhiro Furuya; Kunihiko Fukuda
Journal:  Eur Radiol       Date:  2017-07-03       Impact factor: 5.315

9.  The association between sonographic enthesitis and radiographic damage in psoriatic arthritis.

Authors:  Ari Polachek; Richard Cook; Vinod Chandran; Dafna D Gladman; Lihi Eder
Journal:  Arthritis Res Ther       Date:  2017-08-15       Impact factor: 5.156

10.  Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis.

Authors:  Reinhardt Maximilian; Claudia Garbe; Jana Petersen; Matthias Augustin; Natalia Kirsten; Mona H C Biermann; Benjamin M Häberle; Kristina Hagenström
Journal:  Acta Derm Venereol       Date:  2021-10-11       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.